Please assess the completion status of the following clinical trial:

Trial Title: A Pilot Evaluation of BLI4900 Bowel Preparation in Adult Subjects

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female outpatients who are undergoing colonoscopy for a routinely accepted indication.~* 18 to 85 years of age (inclusive).~* If female, and of child-bearing potential, is using an acceptable form of birth control (hormonal birth control, IUD, double-barrier method, depot contraceptive, abstinent, or vasectomized spouse).~* Negative urine pregnancy test at screening, if applicable.~* In the Investigator's judgment, subject is mentally competent to provide informed consent to participate in the study.~Exclusion Criteria:~* Subjects with known or suspected ileus, severe ulcerative colitis, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or megacolon.~* Subjects with ongoing severe, acute inflammatory bowel disease.~* Subjects who had previous significant gastrointestinal surgeries.~* Subjects with uncontrolled pre-existing electrolyte abnormalities, or those with clinically significant electrolyte abnormalities based on Visit 1 laboratory results.~* Subjects with uncontrolled hypertension (systolic blood pressure \> 170 mmHg and diastolic blood pressure \> 100 mmHg).~* Subjects with severe renal insufficiency (GFR \< 30 mL/min/1.73m2).~* Subjects with known severe hepatic insufficiency (Child Pugh C).~* Subjects with cardiac insufficiency (NYHA Functional Classifications 3 or 4).~* Subjects undergoing insulin therapy for any indication.~* Subjects with impaired consciousness that predisposes them to pulmonary aspiration.~* Subjects undergoing colonoscopy for foreign body removal and/or decompression.~* Subjects who are pregnant or lactating, or intending to become pregnant during the study.~* Subjects of childbearing potential who refuse a pregnancy test.~* Subjects allergic to any preparation components.~* Subjects who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures.~* Subjects who have participated in an investigational surgical, drug, or device study within the past 30 days.~* Subjects who withdraw consent before completion of Visit 1 procedures.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- BLI4900 (Type: EXPERIMENTAL): BLI4900 Bowel Preparation
- PEG Control (Type: ACTIVE_COMPARATOR): Polyethylene glycol-based bowel preparation

Based on this trial design, predict the completion outcome and termination type (if applicable).